Our findings demonstrate that SUMO1 inhibition negatively regulates the tumorigenic properties of cancer cells via two different mechanisms: (1) stimulation of autophagy-mediated cancer cell death, and (2) inhibition of cancer cell invasiveness via regulation of RAC1 SUMOylation. The gene discussed is RAC1; the disease is cancer.